Page last updated: 2024-10-31

w 12 and Colitis, Granulomatous

w 12 has been researched along with Colitis, Granulomatous in 3 studies

W 12: calmodulin antagonist; W13 analog with Cl deleted from benzene ring

Research Excerpts

ExcerptRelevanceReference
"Both the Crohn's disease exclusion diet combined with partial enteral nutrition (CDED+PEN) and exclusive enteral nutrition (EEN) can induce remission in mild-to-moderate pediatric Crohn's disease and are associated with a marked decrease in fecal kynurenine levels."3.30Sustained Diet-Induced Remission in Pediatric Crohn's Disease Is Associated With Kynurenine and Serotonin Pathways. ( Benninga, MA; Boneh, RS; de Jonge, WJ; Emond, P; Ghiboub, M; Lefèvre, A; Sovran, B; Van Limbergen, JE; Verburgt, CM; Wine, E, 2023)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's3 (100.00)2.80

Authors

AuthorsStudies
Ghiboub, M2
Penny, S1
Verburgt, CM2
Boneh, RS2
Wine, E2
Cohen, A1
Dunn, KA1
Pinto, DM1
Benninga, MA2
de Jonge, WJ2
Levine, A1
Van Limbergen, JE2
Dong, X1
Chen, X1
Ren, Y1
Sovran, B1
Lefèvre, A1
Emond, P1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Comparison of Partial Enteral Nutririon (Modulen) With a Unique Diet to Exclusive Enteral Nutrition (Modulen) for the Treatment of Pediatric Crohn's Disease. A Prospective Randomized Controlled Trial.[NCT01728870]74 participants (Actual)Interventional2013-01-31Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trials

2 trials available for w 12 and Colitis, Granulomatous

ArticleYear
Metabolome Changes With Diet-Induced Remission in Pediatric Crohn's Disease.
    Gastroenterology, 2022, Volume: 163, Issue:4

    Topics: Arginine; Ceramides; Child; Crohn Disease; Diet; Humans; Kynurenine; Metabolome; Prospective Studies

2022
Sustained Diet-Induced Remission in Pediatric Crohn's Disease Is Associated With Kynurenine and Serotonin Pathways.
    Inflammatory bowel diseases, 2023, 05-02, Volume: 29, Issue:5

    Topics: Child; Crohn Disease; Diet; Humans; Kynurenine; Melatonin; Prospective Studies; Quinolinic Acid; Rem

2023

Other Studies

1 other study available for w 12 and Colitis, Granulomatous

ArticleYear
MALT1 reflects inflammatory cytokines, disease activity, and its chronological change could estimate treatment response to infliximab in Crohn's disease patients.
    Journal of clinical laboratory analysis, 2022, Volume: 36, Issue:10

    Topics: C-Reactive Protein; Crohn Disease; Cytokines; Humans; Inflammation; Infliximab; Interleukin-17; Leuk

2022